Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
ANTWERP, Belgium and ZÜRICH, December 12, 2013 /PRNewswire/ --
genae, a global Contract Research Organization (CRO) and services provider for the medical devices industries, today announced the incorporation of genae International AG.
The centrally located Swiss services facility will support the group's expanding operations and forms the second base in Europe.
"The Swiss offices reflect the growing demand of our strategic partners to provide local presence and tailored support," said Bart Segers, CEO at genae. "With local anchoring, we aim at accelerating high-quality and cost-contained recruitment and execution of our medical device trials in Switzerland and other European countries."
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice.
genae is a full service CRO and an innovative services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group is ISO 9001 certified for clinical trial management, data management, statistical analysis, safety, regulatory, core laboratory and medical writing services for the medical industries.
genae associates nv is a privately held company with principal offices in Antwerp, Belgium.
Please visit: http://www.genae.com
genae associates nv, Justitiestraat 6B, 2018 Antwerp, Belgium
genae International AG, Europaallee 41, 8021 Zürich, Switzerland
genae Americas, Inc., GCIC, 10000 Cedar Avenue, Cleveland, OH 44106, USA
Bart Segers, CEO
©2012 PR Newswire. All Rights Reserved.